Oligomerisation of G-protein-coupled receptors.

A range of approaches have recently provided evidence that G-protein-coupled receptors can exist as oligomeric complexes. Both homo-oligomers, comprising multiple copies of the same gene product, and hetero-oligomers containing more than one receptor have been detected. In several, but not all, examples, the extent of oligomerisation is regulated by the presence of agonist ligands, and emerging evidence indicates that receptor hetero-oligomers can display distinct pharmacological characteristics. A chaperonin-like role for receptor oligomerisation in effective delivery of newly synthesised receptors to the cell surface is a developing concept, and recent studies have employed a series of energy-transfer techniques to explore the presence and regulation of receptor oligomerisation in living cells. However, the majority of studies have relied largely on co-immunoprecipitation techniques, and there is still little direct information on the fraction of receptors existing as oligomers in intact cells.

[1]  B. Bettler,et al.  Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. , 1997, Nature.

[2]  A. Cornea,et al.  Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.

[3]  H. Akil,et al.  Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. , 2000, Molecular pharmacology.

[4]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Blumer,et al.  G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.

[6]  G. Köhr,et al.  Role of heteromer formation in GABAB receptor function. , 1999, Science.

[7]  Alan Wise,et al.  Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.

[8]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[9]  C. Martínez-A,et al.  HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Morrison,et al.  Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells* , 1997, The Journal of Biological Chemistry.

[11]  P. Vallotton,et al.  Fluorescence techniques: shedding light on ligand-receptor interactions. , 2000, Trends in pharmacological sciences.

[12]  H. Lother,et al.  AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.

[13]  J. Fritschy,et al.  GABAB receptors make it to the top--as dimers. , 1999, Trends in pharmacological sciences.

[14]  T. Gudermann,et al.  Structural Implication for Receptor Oligomerization from Functional Reconstitution Studies of Mutant V2 Vasopressin Receptors* , 2000, The Journal of Biological Chemistry.

[15]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.

[16]  K. Ray,et al.  Cys-140 Is Critical for Metabotropic Glutamate Receptor-1 Dimerization* , 2000, The Journal of Biological Chemistry.

[17]  Kenneth A. Jones,et al.  GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 , 1998, Nature.

[18]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[19]  C. Martínez-A,et al.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Rees,et al.  Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.

[21]  G. Milligan New Aspects of G-Protein-Coupled Receptor Signalling and Regulation , 1998, Trends in Endocrinology & Metabolism.

[22]  S. Russek,et al.  Molecular Identification of the Human GABABR2: Cell Surface Expression and Coupling to Adenylyl Cyclase in the Absence of GABABR1 , 1999, Molecular and Cellular Neuroscience.

[23]  R. Lefkowitz,et al.  Heptahelical Receptor Signaling: Beyond the G Protein Paradigm , 1999, The Journal of cell biology.

[24]  J. Wess,et al.  Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. , 1998, Biochemistry.

[25]  S. Nakanishi,et al.  Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. , 2000, The Journal of biological chemistry.

[26]  T. Gudermann,et al.  Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. , 1997, Molecular endocrinology.

[27]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[29]  R Levenson,et al.  The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. , 2000, Molecular pharmacology.

[30]  Urs Gerber,et al.  G-protein-independent signaling by G-protein-coupled receptors , 2000, Trends in Neurosciences.

[31]  M. Scarselli,et al.  Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments. , 2000, European journal of pharmacology.

[32]  Christopher A Reynolds,et al.  Dimerization and Domain Swapping in G-Protein-Coupled Receptors: A Computational Study , 2000, Neuropsychopharmacology.

[33]  G. Wallukat,et al.  From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists. , 2000, Molecular pharmacology.

[34]  P. Seeman,et al.  Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.

[35]  C. Romano,et al.  Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.

[36]  R. Shigemoto,et al.  GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.

[37]  Jilly F. Evans,et al.  Identification of a GABAB Receptor Subunit, gb2, Required for Functional GABAB Receptor Activity* , 1999, The Journal of Biological Chemistry.

[38]  J. Chambers,et al.  Orphan G‐protein‐coupled receptors: the next generation of drug targets? , 1998, British journal of pharmacology.

[39]  E I Canela,et al.  Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Michel Bouvier,et al.  Functional Significance of Oligomerization of G-protein-coupled Receptors , 2000, Trends in Endocrinology & Metabolism.

[41]  M. Bouvier,et al.  Functional rescue of a constitutively desensitized beta2AR through receptor dimerization. , 1998, The Biochemical journal.

[42]  S. Angers,et al.  Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. , 2000, The Journal of clinical investigation.

[43]  C. Martínez-A,et al.  The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  S. Coughlin,et al.  PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.

[45]  D. Jenness,et al.  Homo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis. , 2000, Molecular biology of the cell.

[46]  F. Marshall,et al.  GABAB receptors - the first 7TM heterodimers. , 1999, Trends in pharmacological sciences.

[47]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[48]  S. Mennerick,et al.  Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization. , 2001, Molecular pharmacology.

[49]  C. Forehand A Peptide. , 1992, Science.

[50]  G. Milligan Receptors as Kissing Cousins , 2000, Science.

[51]  R. Heim,et al.  Using GFP in FRET-based applications. , 1999, Trends in cell biology.

[52]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[53]  J. Wess,et al.  Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co‐expressed receptor polypeptide. , 1996, The EMBO journal.

[54]  N. Prévost,et al.  Thrombin Responses in Human Endothelial Cells , 2000, The Journal of Biological Chemistry.

[55]  Pierre Corvol,et al.  Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling , 1996, The Journal of Biological Chemistry.

[56]  M. Bouvier,et al.  Export from the Endoplasmic Reticulum Represents the Limiting Step in the Maturation and Cell Surface Expression of the Human δ Opioid Receptor* , 2000, The Journal of Biological Chemistry.

[57]  U. Kumar,et al.  Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.

[58]  T. Asano,et al.  Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells 1 , 1997, FEBS letters.

[59]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[60]  U. Kumar,et al.  Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.

[61]  J. Wess,et al.  Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.

[62]  H. Lother,et al.  Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization* , 1999, The Journal of Biological Chemistry.

[63]  Michel Bouvier,et al.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000 .

[64]  A Minarini,et al.  Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor. , 1998, European journal of pharmacology.

[65]  G. Corsini,et al.  Functional Role of the Third Cytoplasmic Loop in Muscarinic Receptor Dimerization* , 1996, The Journal of Biological Chemistry.

[66]  Y. Jan,et al.  A Trafficking Checkpoint Controls GABAB Receptor Heterodimerization , 2000, Neuron.